Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Bioinformatics and Data Analysis for Biomarker Research

Active

Federal

Response Deadline08/07/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract titled Bioinformatics and Data Analysis for Biomarker Research seeks to deliver computational analysis of high-throughput sequencing data with the goal of identifying and validating biomarker signatures, accompanied by the generation of detailed research reports. This effort is classified as a subcontract under NAICS code 541714 and is managed by the Department of Veterans Affairs through its 245-NETWORK Contract Office 5. The work is to be performed at a location in Washington, D.C., with a zip code of 20422. The opportunity was posted on July 24, 2026, and responses are due by August 7, 2026, at 5:00 PM EST. Although no specific set-aside designation is indicated, the contract is structured to support advanced bioinformatics capabilities essential for translational research in biomarker discovery.

General Info

Bioinformatics subcontract to analyze sequencing data for biomarker discovery in Washington, D.C., due August 7, 2026.

Agency

Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)View Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Washington, DC, 20422, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 24

subcontract

Response DeadlineAug 7

Submission deadline

Response Deadline

08/07/2026, 05:00:00 PM UTCin 12 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Provide computational analysis of high-throughput sequencing data to identify and validate biomarker signatures and generate research reports.

Similar Contracts

Same NAICS industry code

Humanized Antibody Library Screening and Transferrin Receptor DevelopmentThe contract involves the customized screening of a humanized antibody library to develop a functional transferrin receptor, encompassing molecular design, in vitro selection, and optimization of binding affinity and specificity. The work requires advanced techniques in antibody engineering to identify and refine candidates capable of high-affinity, selective interaction with the transferrin receptor, with the goal of producing a therapeutically viable candidate. The scope includes iterative cycles of library screening, functional characterization, and structural optimization to enhance target binding while minimizing off-target interactions, ensuring the final product meets stringent performance benchmarks. This subcontract is issued under the NAICS code 541714 for research and development in the biological sciences and is associated with the National Institutes of Health through the Department of Health and Human Services. The place of performance is in Bethesda, Maryland, with a deadline for proposals set for July 31, 2026. The contract is expected to support biomedical innovation targeting receptor-mediated delivery systems and requires expertise in molecular biology, high-throughput screening, and protein engineering. No specific set-aside provisions are indicated, and the work is open to qualified subcontractors capable of delivering scalable, data-driven antibody development solutions within the defined timeline.

National Institutes Of Health Olao

POSTED

DEADLINE

Recombinant Antibody Discovery & Engineering ServicesThe contract involves the discovery, humanization, and engineering of single domain antibodies designed to penetrate the blood-brain barrier using phage and yeast display platforms. This effort includes advanced antibody optimization through affinity maturation to enhance binding strength and specificity, as well as comprehensive stability testing to ensure functional integrity under physiological conditions. The work is scientifically focused on developing recombinant antibody formats capable of crossing the blood-brain barrier, a critical step for therapeutic applications targeting neurological diseases. This subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 541714 for research and development in the physical, engineering, and life sciences. The opportunity was posted on July 24, 2026, with a response deadline of August 3, 2026. Performance is expected to take place in Bethesda, Maryland, 20892. The project does not specify a set-aside type or point of contact details, and the full solicitation can be accessed via the provided SAM.gov link for additional procedural or submission guidelines.

National Institutes Of Health Olao

POSTED

DEADLINE

Develop and Validate Transferrin ReceptorThe National Institutes of Health, under the Department of Health and Human Services, has issued a presolicitation notice for the development and validation of a transferrin receptor, identified by solicitation number 75N98026Q00866. This opportunity is open for responses until July 31, 2026, and was posted on July 24, 2026, with no set-aside provisions applied, making it open to all eligible entities. The work will be performed in Bethesda, Maryland, and falls under the NAICS code 541714, which corresponds to research and development in the physical, engineering, and life sciences. The primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. Interested parties are directed to the official SAM.gov workspace link for further details and submission guidelines. The contract aims to support advanced scientific research focused on the transferrin receptor, likely to advance biomedical applications or therapeutic technologies. All proposals must adhere to the requirements outlined in the notice of intent, and submissions should be prepared with consideration for the technical scope, timeline, and performance standards expected by the NIH Office of Laboratory Animal Welfare. The contract is structured to enable innovation in molecular biology or drug delivery systems involving receptor targeting, with performance expected within the confines of federal research protocols and compliance standards.

National Institutes Of Health Olao

POSTED

DEADLINE

Humanized single domain antibodies for therapeutic brain deliveryThe National Institutes of Health Office of Extramural Research, under the Department of Health and Human Services, has issued a presolicitation for the development of humanized single domain antibodies designed for therapeutic delivery across the blood-brain barrier. The project, identified by solicitation number 75N98026Q00867, aims to advance novel antibody technologies capable of targeting brain-specific pathologies with enhanced precision and efficacy. All responses are due by August 3, 2026, and no set-aside provisions are applicable, meaning the opportunity is open to all eligible entities. The performance location is designated as Bethesda, Maryland, with the contract administration handled by the agency’s office at 20892. Primary point of contact for inquiries is Towanda Daniels, reachable via email at danielt@mail.nih.gov. The solicitation was posted on July 24, 2026, and all potential offerors are directed to the designated SAM.gov workspace for additional details and documentation. No NAICS code has been assigned at this stage, and the initiative reflects a strategic effort to enable breakthrough treatments for neurological disorders through innovative biotherapeutic platforms. Applicants must ensure full compliance with the requirements outlined in the attached Notice of Intent.

National Institutes Of Health Olao

POSTED

DEADLINE

Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakThe Food and Drug Administration is planning to award a sole source firm-fixed price purchase order to The University of Liverpool under simplified acquisition procedures for the sequencing of Bundibugyo virus disease during the 2026 outbreak, relying on FAR Part 6.103-1 which permits non-competitive procurement when only one responsible source exists. This action falls under the NAICS code 541714 for Research and Development in Biotechnology and is not open for competitive bidding, as the FDA has determined that The University of Liverpool is the only entity with the necessary expertise and capacity to meet the technical requirements for this highly specific viral sequencing effort. The contract is intended to support bioanalytical method development and sample analysis by providing critical reagents and reference standards for quantifying CYP enzyme substrates and metabolites in hepatocyte experiments during the outbreak response. Responses to this notice must be submitted by Ryan Alexander at ryan.alexander@fda.hhs.gov no later than 5:00 pm on July 29, 2026, and must include a detailed capability statement for any other organization seeking consideration, though the government retains full discretion to determine whether a response justifies competitive solicitation. The procurement is not a request for competitive quotes, and no set-aside is being applied. The contract will be administered from the FDA’s office in Rockville, Maryland, with performance primarily occurring in Liverpool, England, and the solicitation number is OC-2026-135667, issued on July 24, 2026.

Food And Drug Administration

POSTED

DEADLINE

Procurement of lateral flow (LFA) strips for the rapid HIV nucleic acid diagnostic testThe Centers for Disease Control and Prevention is soliciting bids for the procurement of 4,000 lateral flow strips intended for use in a rapid HIV nucleic acid diagnostic test under a firm-fixed-price contract, issued as a Request for Quote in accordance with FAR Subpart 12 for commercial items. The solicitation number is 75D30126Q79099, with a performance period of August 1, 2026, to December 31, 2026, and an option to extend services for up to six additional months. Proposals must be submitted electronically to Eugene Gutierrez at zvm0@cdc.gov no later than 3:00 P.M. Eastern Standard Time on Friday, July 24, 2026, with no telephonic or paper submissions accepted. The place of performance is the CDC facility at 1600 Clifton Road, Building 17, Atlanta, GA 30329-4018. Offerors must be registered in the System for Award Management at the time of submission and are required to comply with all applicable FAR clauses, including 52.212-1 and 52.212-4, along with deviations such as those addressing trafficking in persons, contractor employee whistleblower rights, sustainable products and services, Buy American Act alternatives for Israeli and Korean end products, and prohibitions on unauthorized information sharing. Technical evaluation is the predominant factor in award, emphasizing experience with biomedical devices, FDA approval processes, and prior work with lateral flow technology, with price considered secondary. The contractor must deliver 200 prototype strips and 4,000 final units meeting stringent performance standards: ≤0.5% false positive rate and ≤1% false negative rate using CDC’s LAMP reaction, and must ensure full compatibility with CDC’s mass production protocols. All deliverables must conform to Section 508 accessibility requirements, including WCAG 2.0 Level AA, and vendors must provide a Voluntary Product Accessibility Template or HHS conformance checklist. The contract imposes strict security and confidentiality obligations, including mandatory non-disclosure agreements for all employees accessing sensitive information, identification protocols to distinguish contractor personnel from government staff, and prohibitions against retaining or disseminating federal records or Privacy Act data. Subcontractors must be bound by the same requirements, and all payments must be processed via the Treasury’s Invoice Processing Platform using an ACH Vendor Enrollment

CDC Office Of Acquisition Services

POSTED

DEADLINE

Illumina Reagent KitsThe United States Department of the Naval Medical Research Command intends to award a sole source contract to Illumina, Inc. of San Diego, California, for the purchase of Illumina Reagent Kits. This procurement is not a competitive solicitation, but responses received will be considered if submitted. The action is classified under NAICS code 541714 and will be conducted under FAR Part 12 guidelines for commercial items. All vendors must be registered in the Systems for Award Management (SAM) and possess a Unique Entity Identification Number (UEI) to be eligible for award, with SAM registration available free of charge through sam.gov or by calling (866) 606-8220. The contract is identified by solicitation number 1301397256, posted on July 23, 2026, with a response deadline of August 7, 2026. The contracting office is located in Silver Spring, Maryland, with performance expected in Frederick, Maryland. Primary point of contact is Shamai Carter, reachable at shamai.m.carter.civ@health.mil, with Nataki Johnson as the secondary contact.

Naval Medical Research Center

POSTED

DEADLINE

Battlefield Pain Management – AnalgesicThis solicitation under the prototype Other Transaction Authority (10 U.S.C. 4022) seeks the development of a single-use analgesic product for acute moderate to severe battlefield pain, with the ultimate goal of obtaining FDA approval. The product must be a combination drug-device system—such as a nasal spray or autoinjector—that is rapid to administer, compact for individual carry, and stable under extreme environmental conditions, capable of withstanding temperature excursions between -25°C and 45°C without refrigeration and maintaining a 2-3 year shelf life at controlled room temperature. It must comply with USP <659> packaging and storage standards, adhere to 21 CFR Part 820 quality system regulations for labeling and control, and meet strict physiological limits including no more than a 20% reduction in baseline blood pressure, heart rate, or blood clotting ability. The product must be classified as a DEA Schedule II or higher controlled substance and must not require special handling for humidity, pressure, or temperature, verified through MIL-STD-810 testing. The effort spans an estimated eight-year period, divided into three sequential objectives: three years for Chemistry, Manufacturing, and Controls (CMC) and stability studies; two years for non-clinical enabling studies; and three years for clinical trials and human factors testing, including potential Emergency Use Authorization (EUA) submission. Deliverables include detailed regulatory documentation, study strategies, interim and final reports, regulatory meeting minutes, protocol approvals from IACUC and ORRC, and full compliance with Controlled Unclassified Information (CUI) marking and data handling protocols. The contract does not fall under FAR or DFARS, but incorporates selected clauses for electronic payment submission, government property management, and termination for convenience. Proposals must be submitted in three volumes—Technical, Management, and Administrative and Cost—with the technical volume limited to 20 pages plus an unlimited attachment for the Statement of Work. A key eligibility requirement is a pass/fail gate: the proposal must demonstrate participation of at least one nontraditional defense contractor or nonprofit research institute, or that all significant participants are small businesses or nontraditional contractors, or that at least one-third of the total project cost is funded by non-federal sources. The proposal deadline has been extended to August 14, 2026, with all submissions required via email in searchable PDF format, compatible with Microsoft Office and Adobe Acrobat, and free of malware, passwords, or hyperlinks.

Defense Health Agency

POSTED

DEADLINE

Development of Light-Responsive Artificial Cells using Plant-Based Photoreceptor SystemsThe United States Army Corps of Engineers Engineer Research and Development Center Construction Engineering Research Laboratory is seeking to develop light-responsive artificial cells by integrating plant-derived UVR8 photoreceptor systems into synthetic biology platforms, using high-throughput protein engineering and AI-assisted structural refinement to create programmable, pseudo-living systems activated by environmental light stimuli. The project aims to advance foundational science in synthetic biology by leveraging Bioconscientia, LLC’s uniquely specialized expertise in UVR8 photoreceptor technology, which enables precise sensing of UV-B light in a manner unmatched by other entities. Due to the highly specialized nature of the required research and Bioconscientia’s irreplaceable knowledge of existing experimental data and technical pathways, the government intends to award a sole-source contract to this vendor under RFO FAR 12.102(a), with an anticipated award date of September 30, 2026. This presolicitation notice, issued under FAR Part 5.101(a) with solicitation number W9132T26QA015 and NAICS code 541714, does not constitute a formal request for proposals or a competitive procurement, nor is it a set-aside. Interested parties may submit capability statements to CERL-CT-QUOTES@USACE.ARMY.MIL by July 31, 2026, to be reviewed for potential technical equivalency, but submission does not guarantee a change to the government’s acquisition strategy. The government retains full discretion to proceed with sole-source award regardless of responses received. All work will be performed in Champaign, Illinois, and the primary point of contact for submissions is Lurline L. Simmons, with Andrea J. Thomas serving as the contracting officer. No telephone inquiries will be accepted.

W2R2 Construction Engrg Labor

POSTED

DEADLINE

AI/ML and Data Analytics for Cardiovascular Device Validation

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is soliciting collaborative participation through a continuous, open Participant Basic Agreement (PBA) under the HEALER portfolio to advance next-generation, threat-agnostic host-directed therapeutics designed to enhance physiological resilience against CBRN threats. This initiative targets five critical biological systems—neurological protection, respiratory stabilization, immune modulation, hematologic and vascular function, and cellular stress and repair pathways—with the goal of developing dual-use medical countermeasures that serve both military and civilian critical care needs. The program invites two categories of collaborators: therapeutic developers with candidates that modulate host response mechanisms and drug development support providers including CROs and CDMOs with capabilities in preclinical testing, clinical trial execution, cGMP manufacturing, regulatory strategy, and advanced modeling. Submission requires a white paper of no more than five pages excluding a cover page, detailing product mechanism of action, efficacy data from validated animal models, regulatory status such as IND experience and clinical trial history, manufacturing capacity and scale-up plans, and company profile for therapeutic developers, or core capabilities and infrastructure for service providers. All participants must express willingness to collaborate with other PBA holders to foster an integrated development ecosystem. The solicitation, issued under statutory authority of 10 U.S.C. §§4021–4023, operates outside the Competition in Contracting Act and does not follow traditional procurement or evaluation frameworks, eliminating standard contract clauses, formal evaluation factors, pricing structures, or submission deadlines. Instead, awards are made at the government’s discretion through a non-traditional acquisition mechanism designed to accelerate innovation. Technical and administrative inquiries are directed to Hunter Robinson and Alexander Mayatte at the U.S. Army’s Aberdeen Proving Ground, Maryland office. Participation prerequisites include current registration in the System for Award Management (SAM), compliance with FDA regulatory pathways, and adherence to cGMP standards for manufacturing. While no specific delivery dates, FOB terms, inspection criteria, or cost estimates are defined, performance is expected to align with the mission of CPE CBRND to enable the Joint Force to operate effectively in CBRN-contested environments. Intellectual property considerations, teaming arrangements, and the scalability of therapeutic candidates are central to selection, with no socioeconomic or size status certifications required. The structure prioritizes agility, collaboration, and cross-sector innovation over rigid compliance, enabling a dynamic pipeline of medical countermeasures capable of addressing evolving biological threats through sustained host resilience.

POSTED

DEADLINE

Non-Optical Methods for High Speed Protein ControlDARPA’s Biological Technologies Office is seeking innovative solutions through the ERIS Marketplace to develop a new class of rapidly switchable, non-optogenetic protein domains capable of enabling real-time, massless control of cellular processes. The goal is to create a robust, modular molecular tool that responds to non-optical external signals such as magnetic fields or focused ultrasound, allowing precise regulation of protein function across cell membranes without relying on light or chemicals. Proposed solutions must achieve activation and deactivation kinetics of no more than two seconds, demonstrate reliable performance through at least 300 repetitive cycles in living cells, and function effectively in both split-protein dimerization and allosteric conformational configurations. This effort explicitly excludes any modifications or enhancements to existing optogenetic, light-based, or chemical systems. The anticipated contract value is $400,000 for a 12-month performance period, with awards being made on a rolling basis as solutions are evaluated, and the government reserves the right to issue awards before the December 8, 2026 submission deadline. Proposals must be submitted via the DARPA Connect ERIS Portal as a video that follows the required title format, or existing awardable solutions may be flagged for consideration by emailing ERIS@darpa.mil with specific subject and body requirements. Evaluation will focus on four core areas: a deep understanding of the problem space and current limitations in fields like sonogenetics and magnetogenetics, a significant technical leap in achieving rapid and repeatable protein control, demonstrated expertise in synthetic biology, protein engineering, and biophysics with a proven track record of quantitative in vivo characterization, and the potential of the solution to become a foundational tool in synthetic biology with broad applications in defense-relevant areas such as biomanufacturing, cell-based therapeutics, and biosensing. All submissions are subject to the ERIS assessment process, which serves as a mandatory pass/fail gate—only solutions deemed awardable by this process will be considered for BTO award. The procuring agency is the Department of Defense through DARPA’s Arlington, VA office, and all participants must comply with the ERIS Master Solicitation requirements available via SAM.gov.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

More opportunities from Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

Same awarding agency

6515--688_Microwave Ablation System (VA-26-00077651)The Washington DC VA Medical Center is seeking information on a replacement microwave ablation system to supplement its current unit, which will reach end of service by September 31, 2026, and has exceeded its five-year HTM life expectancy. The system is critical for oncology treatments targeting kidney, liver, and lung cancers, used two to three times per week in interventional radiology. The procurement must include the IntelliBlate Microwave Ablation System with MyAblation Guide deployed on Syngo.via View & Go, fully compatible with the facility’s existing software. The system requires specific technical features including dual peristaltic pumps, a 15.6-inch foldable touchscreen operable with gloves and sterile drapes, tract ablation and needle lock capabilities, 2.45 GHz ± 50 MHz frequency output, independent dual-channel control with power outputs up to 90 W single channel and 80 W per channel for dual use, and precise temperature measurement across a 10–100°C range with defined accuracy tolerances. The unit must weigh no more than 95 lbs with cart, fit within specified dimensions, and operate on 100–240 VAC. All equipment must be sourced through manufacturer-approved channels and covered by a full warranty. The response to this request for information is strictly for planning purposes and does not constitute a solicitation, bid, or binding obligation. All submissions must include full company details, DUNS/CAGE/SAM UEI, business size, manufacturer or distributor status, country of origin, technical literature proving equivalence to the specified system, and an authorized distributor letter certified by the OEM. The government will not issue evaluation results or accept any responses as offers. Any resulting contract will be issued through a separate future solicitation. If selected, the contractor must deliver the equipment within 90 days of award to the DC VAMC at 50 Irving St NW, Washington, DC 20422, coordinate delivery with the designated point of contact, adhere to on-site protocols including COVID-19 screening and mask requirements, ensure all removable media is scanned for malware prior to use, remove hard drives from returned or replaced equipment, and provide comprehensive training to clinical staff covering operation, maintenance, safety, and troubleshooting. Final acceptance requires a joint inspection with the facility’s team, with all identified deficiencies resolved before government acceptance. The contractor must also submit within 10 business days of completion a service report, warranty

Surgical and Medical Instrument Manufacturing

POSTED

about 19 hours ago

DEADLINE

7310--COMBI OVENS | 540-26-3-123-0010 (VA-26-00077683)The contract is a request for quotations under solicitation number 36C24526Q0686, issued by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5 for the procurement of two Vulcan Chef-102G full-size combi ovens and associated accessories including steam generators, installation kits, water treatment systems, and carbon filters for the Louis A. Johnson VAMC kitchen renovation project. The acquisition is set aside exclusively for Service-Disabled Veteran-Owned Small Businesses (SDVOSB) under NAICS code 333310 with a size standard of 1,000 employees, and compliance with FAR Part 12 commercial item acquisition procedures is required. All deliveries must be made to BOVA Corporation at 111 McFann Rd, Valencia, PA 16059 by September 30, 2026, with FOB destination terms placing responsibility for transportation, risk, and insurance on the vendor until receipt at the delivery location. The ovens must meet UL safety standards, HACCP-compliant operational requirements, and include remote monitoring and data logging capabilities. Water treatment system accessories—specifically a single hollow carbon filter system with 15,000-gallon capacity, a scale blocker, and a water softening system with 2,527-grain capacity—are required, with offerors expected to specify model numbers for each. The government will evaluate submissions based on technical capability, past performance, and price, with intent to award without discussions, indicative of a Low Price Technically Acceptable approach though not explicitly confirmed. The solicitation mandates full compliance with numerous FAR clauses including Buy American Act certifications, prohibitions on child labor and human trafficking, DEI non-discrimination obligations, SAM registration, electronic funds transfer payments, and prohibitions on internal confidentiality agreements that inhibit whistleblower reporting. Proposals must be submitted via email to Alison.Klein@va.gov by August 4, 2026, and must include the Unique Entity Identifier, certifications, and affirmation of all solicitation terms. The contracting officer, Alison Klein, is the sole point of contact for submissions, while delivery coordination must be arranged with BOVA Corporation prior to shipment. No pricing details are provided in the solicitation, as this information is to be submitted by offerors. Compliance with packaging, labeling, and documentation requirements—including inclusion of the VA purchase order number on packing slips and provision of Safety Data Sheets

Commercial and Service Industry Machinery Manufacturing

POSTED

about 19 hours ago

DEADLINE

6515--688 Middle Ear Analyzers (VA-26-00077961)The DC VA Medical Center is seeking to purchase six Interacoustics Titan V1 Diagnostic Middle Ear Analyzers and one comprehensive setup and installation service to expand its audiological diagnostic capabilities, ensuring consistent, high-quality care for Veterans across all auditory booths. The requirement is for commercial products and services under a Full and Open competition using streamlined procedures per FAR Subpart 12.202, with the NAICS code 339112 and a small business size standard of 1,000 employees. Each device must fully support middle ear and cochlear function testing including tympanometry, acoustic reflex testing, OAE, and compatibility with NOAH software, while offering both handheld and PC operation modes and generating clear graphical outputs for rapid clinical interpretation. The procurement includes all necessary components, licensure, installation, and training, and must be sourced through a manufacturer-approved channel with full manufacturer warranty coverage. Quotes must be submitted by August 6, 2026, to the designated email addresses, and must include a statement confirming acceptance of all solicitation terms without modification, along with any exceptions and rationale. Offerors must be registered in SAM, comply with Buy American provisions, certify adherence to child labor and human trafficking prohibitions, and meet all applicable representations including those related to cybersecurity, subcontracting, and payment terms. The equipment must be delivered within 90 days of contract award to the Washington DC VA Medical Center. Evaluation will be based on a comparative assessment of technical capability, past performance, and price under simplified acquisition procedures. Late submissions will not be considered unless accepted under exceptional circumstances, and the Government reserves the right to negotiate or reject any offer in the public interest. All questions must be directed in writing to the Contracting Officer prior to the deadline.

Surgical and Medical Instrument Manufacturing

POSTED

about 19 hours ago

DEADLINE

Specimen Logistics and Chain-of-Custody ManagementThe contract requires the secure transport and management of temperature-controlled biological specimens between U.S. Department of Veterans Affairs facilities and a University of Wisconsin laboratory, with strict adherence to cold chain standards to preserve specimen integrity. All activities must include comprehensive documentation of the chain of custody to ensure accountability, traceability, and compliance with regulatory requirements throughout the transit process. The work involves coordinating logistics across multiple VA sites and the external lab, utilizing appropriate packaging, monitoring systems, and transportation protocols to prevent temperature excursions and contamination. The solicitation is classified as a subcontract under NAICS code 484220, indicating it pertains to general freight trucking, with performance centered in Washington D.C., though operations may extend across VA network locations. The opportunity was posted on July 24, 2026, with a response deadline of August 7, 2026, at 5:00 p.m. EDT. The contracting office is the 245-NETWORK Contract Office 5 under the Department of Veterans Affairs, and bidders must be prepared to meet rigorous security, handling, and reporting standards for biological materials without deviations from established protocols. Failure to maintain documented provenance or temperature compliance may result in rejection of specimens and contract noncompliance.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Biopsy Specimen Molecular ProfilingThe contract is for molecular profiling of solid tumor biopsy specimens to support veteran health research, encompassing comprehensive DNA and RNA analysis, mutation detection, gene expression profiling, and epigenetic characterization. The work will focus on advancing understanding of tumor biology through advanced genomic technologies to improve clinical outcomes for veterans. The solicitation is structured as a subcontract under NAICS code 541940, indicating it falls under scientific research and development services, and is managed by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5. The place of performance is in Washington, D.C., with a specific zip code of 20422, and responses must be submitted by August 7, 2026, at 5:00 PM Eastern Time. The opportunity was posted on July 24, 2026, and while no set-aside type is specified, it is intended for entities capable of delivering high-complexity molecular diagnostic services in a research context.

Veterinary Services

POSTED

DEADLINE

Circulating Biomarker Molecular Analysis ServicesThe contract seeks a subcontractor to perform molecular analysis of circulating biomarkers including cell-free DNA, RNA, and exosomes derived from blood samples of veterans. The scope of work involves the full pipeline of sample processing, from extraction and sequencing to bioinformatic interpretation, requiring advanced laboratory capabilities and expertise in genomic data analysis. All work must be conducted with precision and compliance with standards appropriate for clinical and research-grade molecular diagnostics, ensuring data integrity and reproducibility. The opportunity is posted under NAICS code 541940 for other scientific and technical consulting services and is managed by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5. The place of performance is designated as Washington DC with a zip code of 20422. Proposals must be submitted by August 7, 2026, at 5:00 PM Eastern Time, following the solicitation posted on July 24, 2026. The contract type is classified as a subcontract, and no specific set-aside designation is indicated.

Veterinary Services

POSTED

DEADLINE

J065--NOTICE OF INTENT TO SOLE SOURCE REQUIREMENT KARL STORZ ENDOSCOPY EQUIPMENT DC VA MEDICAL CENTER DEPT. VETERANS AFFAIRSThis contract establishes a comprehensive service agreement for the maintenance and repair of Karl Storz endoscopy and imaging equipment at the Washington DC VA Medical Center, covering a wide array of devices including camera systems, scopes, light sources, monitors, instruments, and accessories across multiple categories such as rigid, flexible, semi-rigid, and specialty endoscopes, as well as electro-mechanical components. The contractor is responsible for providing all labor, tools, materials, and OEM-certified parts necessary to perform both preventative and corrective maintenance in strict accordance with the manufacturer’s specifications and recommended frequencies. All work must be performed by technicians who are factory-trained and certified by Karl Storz, and proof of training must be available upon request. The contract ensures unlimited on-site corrective services and exchanges for damaged or malfunctioning equipment, with replaced or exchanged parts becoming the property of Karl Storz, and loaner equipment may be provided when available. The contractor must also implement all software updates and patching as directed by Biomedical Engineering and maintain system functionality through rigorous verification testing. Service delivery is governed by strict operational protocols, including normal business hours from 8 a.m. to 4 p.m., Monday through Friday, excluding federal holidays, with after-hours work requiring prior coordination. The contractor must respond to service calls within thirty minutes and dispatch technicians no later than the next business day. All personnel must check in and out with the Biomedical Engineering department, sign in using official logs, and have their tool bags inspected upon arrival and departure. Strict policies govern the handling of patient health information, prohibiting the removal of any storage media containing PHI, and requiring immediate reporting of any breaches. The contractor must comply with OSHA regulations, VA infection control standards, and the campus-wide non-smoking policy, while wearing visible identification at all times. Waste generated during service must be properly removed and disposed of, and any damage to government property must be reported and repaired at the contractor’s expense. The contractor is required to submit detailed service reports within five business days and validate OEM coverage upon award, with invoicing subject to strict compliance requirements and payment made in arrears. A 90-day guarantee covers all workmanship and parts, and potential contractors may inspect equipment prior to bid submission upon coordination with Biomedical Engineering.

Electronic and Precision Equipment Repair and Maintenance

POSTED

DEADLINE

Molecular Analysis of Circulating Biomarkers and Biomarkers and Biopsy Specimens AnalysisThe Department of Veterans Affairs through its Network Contract Office 5 is seeking proposals for the molecular analysis of circulating biomarkers and biopsy specimens under solicitation number 36C24526Q0703. This effort, titled Molecular Analysis of Circulating Biomarkers and Biopsy Specimens Analysis, is aimed at advancing diagnostic and therapeutic research by examining biological markers in blood and tissue samples from veteran populations. The work will be conducted in collaboration with the University of Wisconsin and is focused on delivering high-precision molecular data to support clinical and translational studies relevant to veteran health outcomes. Proposals must be submitted by August 7, 2026, with the government planning to award a contract following a thorough evaluation process. The contract falls under NAICS code 541715 for research and development in the physical, engineering, and life sciences and is not subject to any small business set-aside provisions. Performance is required in Washington, District of Columbia, with the contracting office located in Linthicum, Maryland. Veronica B. Dillard serves as the primary point of contact for inquiries, with all official communication routed through her email address. Interested parties must review the full solicitation details on the SAM. gov portal to ensure compliance with technical requirements, deliverables, and timeline mandates, as this effort supports critical biomedical research initiatives under the VA’s mission to improve healthcare for veterans through innovative diagnostics and personalized medicine approaches.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Reporting and Candidate Recommendation SynthesisThe contract involves compiling and synthesizing candidate evaluation data from resume reviews, interviews, and reference checks into concise summary reports and shortlisted candidate pools for decision-makers at VCL. The work requires transforming qualitative and quantitative assessment data into actionable insights, presented through dashboards and performance metrics to support informed hiring decisions. All deliverables must be structured for clarity and utility, ensuring leadership can quickly assess candidate suitability and make timely selections. The contract is classified as a subcontract under NAICS code 561312 and is managed by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5. Performance is expected to take place in Washington, D.C., with a firm deadline for responses on August 5, 2026. The solicitation was posted on July 23, 2026, and while no set-aside designation is specified, interested parties must prepare and submit proposals within the designated timeframe to be considered for award.

Executive Search Services

POSTED

DEADLINE

Recruitment Event Participation and Talent OutreachThe contract calls for active participation in recruitment events such as job fairs, university outreach programs, and other talent engagement initiatives to represent VA/VCL and attract qualified candidates to employment opportunities within the Department of Veterans Affairs. The work involves traveling to and engaging at various event locations to promote veterans' employment pathways, build relationships with educational institutions and professional networks, and ensure visibility of VA/VCL career options among target demographics. Performance is expected to occur primarily in Washington, D.C., with a zip code of 20422, and the subcontract is governed under NAICS code 561312, which pertains to employment placement agencies. The opportunity was posted on July 23, 2026, with a firm deadline for responses on August 5, 2026, at 2:00 PM. The contract is managed by the 245-NETWORK Contract Office 5 under the Department of Veterans Affairs, and no specific set-aside designation has been assigned.

Executive Search Services

POSTED

DEADLINE

Reference Checking and Candidate VerificationThe contract encompasses reference checking and candidate verification services using VCL-formatted tools to validate employment history, job performance, and professional qualifications of individuals under review. The work requires thorough documentation of findings and formal submission to VCL in accordance with specified protocols, ensuring accurate and reliable verification outcomes. The scope is limited to conducting external checks and delivering processed results without extending to hiring decisions or internal personnel actions. This subcontract is issued under the Department of Veterans Affairs through the 245-NETWORK Contract Office 5, with performance based in Washington, D.C., under the NAICS code 561312 for employment placement services. The solicitation was posted on July 23, 2026, and responses must be submitted by August 5, 2026, at 2:00 p.m. Eastern Time. There is no set-aside designation applied, and the contract does not specify point of contact details beyond the official posting link. All deliverables must align with VCL’s technical requirements and reporting standards to meet compliance obligations.

Executive Search Services

POSTED

DEADLINE

Structured Telephonic Interviewing ServicesThe contract requires the provision of structured telephonic interviewing services for job candidates, utilizing officially approved question sets to ensure consistency and compliance. Contractors must conduct standardized interviews over the phone and submit accurate, timely reports to VCL officials that meet all specified regulatory and procedural standards. The work is classified as a subcontract under NAICS code 561312, with performance expected to be centered in Washington, DC, at the ZIP code 20422. The opportunity was posted on July 23, 2026, and responses are due by August 5, 2026, at 2:00 PM Eastern Time. The contracting office is the 245-NETWORK Contract Office 5 under the Department of Veterans Affairs, and no set-aside provisions have been designated for this solicitation.

Executive Search Services

POSTED

DEADLINE